Cite

HARVARD Citation

    Aman, J. et al. (2021). Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial. Lancet. 9 (9), pp. 957-968. [Online]. 
  
Back to record